Clinical Trial Update: A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating bismuth tripotassium dicitrate (De-Nol) with pantoprazole versus pantoprazole alone for NSAID-induced gastropathy; study termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nsaid-induced Gastropathy

Drugs mentioned

• Bismuth Tripotassium Dicitrate (De-Nol) (bismuth tripotassium dicitrate)
• Pantoprazole (pantoprazole)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: NSAID-induced Gastropathy | Phase 4 | Status: TERMINATED